These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11400000)
41. Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir. Dieleman JP; van Rossum AM; Stricker BC; Sturkenboom MC; de Groot R; Telgt D; Blok WL; Burger DM; Blijenberg BG; Zietse R; Gyssens IC J Acquir Immune Defic Syndr; 2003 Feb; 32(2):135-42. PubMed ID: 12571522 [TBL] [Abstract][Full Text] [Related]
42. Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients. Brodie SB; Keller MJ; Ewenstein BM; Sax PE AIDS; 1998 Dec; 12(18):2433-7. PubMed ID: 9875581 [TBL] [Abstract][Full Text] [Related]
43. [Urinary calculi and crystalluria in HIV+ patients treated with indinavir sulfate]. Daudon M; Estépa L; Kébédé M; Viard JP; Montagnac R; Deray G; Bricaire F Presse Med; 1997 Nov; 26(34):1612-5. PubMed ID: 9452724 [TBL] [Abstract][Full Text] [Related]
44. Influence of environmental temperature on incidence of indinavir-related nephrolithiasis. Martínez E; Leguizamón M; Mallolas J; Miró JM; Gatell JM Clin Infect Dis; 1999 Aug; 29(2):422-5. PubMed ID: 10476752 [TBL] [Abstract][Full Text] [Related]
45. Indinavir crystalluria in an HIV-positive man. Hachey DM; Force RW; Schott J; O'Leary-Jepsen E Ann Pharmacother; 2000 Mar; 34(3):403. PubMed ID: 10917391 [No Abstract] [Full Text] [Related]
46. Rapid development of indinavir-induced asymptomatic crystalluria in a human immunodeficiency virus-negative patient. Antony SJ Clin Infect Dis; 1998 Oct; 27(4):911-2. PubMed ID: 9798063 [No Abstract] [Full Text] [Related]
47. Ureteric obstruction in HIV patients undergoing indinavir therapy. Yanez MH AJR Am J Roentgenol; 1999 May; 172(5):1452. PubMed ID: 10227542 [No Abstract] [Full Text] [Related]
48. Ureteral obstruction secondary to indinavir in the pediatric HIV population. Noble CB; Klein LT; Staiman VR; Neu N; Hensle TW; Berdon WE Pediatr Radiol; 1998 Aug; 28(8):627-9. PubMed ID: 9716639 [TBL] [Abstract][Full Text] [Related]
49. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS. Scelsa SN; MacGowan DJ; Mitsumoto H; Imperato T; LeValley AJ; Liu MH; DelBene M; Kim MY Neurology; 2005 Apr; 64(7):1298-300. PubMed ID: 15824372 [TBL] [Abstract][Full Text] [Related]
50. Increased incidence of indinavir nephrolithiasis in patients with hepatitis B or C virus infection. Malavaud B; Dinh B; Bonnet E; Izopet J; Payen JL; Marchou B Antivir Ther; 2000 Mar; 5(1):3-5. PubMed ID: 10846585 [TBL] [Abstract][Full Text] [Related]
51. [Ureteral lithiasis caused by Indinavir]. Valero G; Leyton R; Valenzuela A Rev Med Chil; 2002 May; 130(5):557-9. PubMed ID: 12143277 [TBL] [Abstract][Full Text] [Related]
52. Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy. Blake SP; McNicholas MM; Raptopoulos V AJR Am J Roentgenol; 1998 Sep; 171(3):717-20. PubMed ID: 9725303 [TBL] [Abstract][Full Text] [Related]
53. [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases]. Chefchaouni MC; Thiounn N; Flam T; Zerbib M; Debré B J Urol (Paris); 1997; 103(1-2):35-6. PubMed ID: 9765778 [TBL] [Abstract][Full Text] [Related]